trial · primary record
PepGNP-COVID19
COVID-19
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-10-21 |
| Primary endpoint | Proportion of participants experiencing Abnormal Clinical Safety Laboratory Adverse Events |
| Registry ID | NCT07183709 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:46.885Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07183709
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.